JANICE EKLUND: Open Payments
NPI 1710981667 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$327 in 17 payments from 6 companies in 2025. Trend: 2023 $436 · 2024 $493 · 2025 $327
Food & beverage: $327
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 8 | $137 |
| Alexion Pharmaceuticals, Inc. | 4 | $77 |
| CATALYST PHARMACEUTICALS, INC. | 2 | $51 |
| Amneal Pharmaceuticals LLC | 1 | $25 |
| Biogen, Inc. | 1 | $19 |
| ARGENX US, INC. | 1 | $17 |
Products named: ULTOMIRIS, Rystiggo, FYCOMPA, Briviact, CREXONT, Nayzilam, TYSABRI, VYVGART.
Industry payments across KY — which companies pay providers there.
